Sacubitril-Valsartan in Heart Failure: The Hard Sell of Spending More to Save Later

Am J Cardiol. 2023 Sep 1:202:237-238. doi: 10.1016/j.amjcard.2023.06.110. Epub 2023 Jul 25.

Authors

Rohan Samson¹, Thierry H Le Jemtel²

Affiliations

¹ Advanced Heart Failure Therapies Program, University of Louisville Health-Jewish Hospital, Louisville, Kentucky. Electronic address: [email protected].
² Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana.

PMID: 37495439
DOI: 10.1016/j.amjcard.2023.06.110

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aminobutyrates / therapeutic use
Angiotensin Receptor Antagonists / therapeutic use
Biphenyl Compounds
Drug Combinations
Heart Failure* / drug therapy
Humans
Stroke Volume
Tetrazoles / therapeutic use
Valsartan

Substances

sacubitril and valsartan sodium hydrate drug combination
Valsartan
Aminobutyrates
Biphenyl Compounds
Drug Combinations
Angiotensin Receptor Antagonists
Tetrazoles